Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1–Nrf2 signalling pathway - Concepedia

Concepedia

Publication | Open Access

Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1–Nrf2 signalling pathway

DOI Full Paper Access

13

Citations

6

References

2021

Year

Ning Hou, Lirong Li, Yongying Shi, Wenchang Yuan, Gan-Jian Zhao, Xia-Wen Liu, Shao-Ai Cai, Yin Huang, Hao-Xin Zhan, Weibiao Pan,

Journal of Pharmacy and Pharmacology

Abstract

Azilsartan restrained pressure overload-induced cardiac remodelling by activating the Keap1-Nrf2 pathway and increasing expression of downstream antioxidant enzymes to alleviate oxidative stress.

References

	Year	Citations

Page 1